Koichiro Nomata Selected Research

Koichiro Nomata Research Topics

Disease

8	Neoplasms (Cancer) 04/2014 - 07/2002
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 02/2006
4	Transitional Cell Carcinoma 06/2006 - 03/2004
3	Neoplasm Metastasis (Metastasis) 02/2013 - 11/2002
3	Carcinoma (Carcinomatosis) 01/2009 - 10/2002
2	Carcinoma in Situ 01/2016 - 06/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2013 - 11/2002
2	Lymphatic Metastasis 01/2005 - 03/2004
1	Hot Flashes 04/2014
1	Prostatic Neoplasms (Prostate Cancer) 04/2014
1	Pain (Aches) 09/2012
1	Leukopenia 09/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2012
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2011
1	Overactive Urinary Bladder (Overactive Bladder) 01/2011
1	Azoospermia 07/2007
1	Oligospermia (Oligozoospermia) 07/2007
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 06/2005
1	Adenocarcinoma 11/2004
1	Ureteral Obstruction 10/2002
1	Non-Muscle Invasive Bladder Neoplasms 10/2002
1	Male Infertility (Male Sterility) 03/2002

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 09/2012 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 01/2009 - 10/2002
3	Connexin 43 (Connexin43)IBA 07/2007 - 10/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2012 - 07/2002
2	Gemcitabine FDA Link 09/2012 - 02/2012
2	TeaIBA 06/2010 - 11/2004
2	Dinoprostone (PGE2)FDA Link 06/2006 - 01/2005
1	bicalutamide (Casodex)FDA LinkGeneric 04/2014
1	AndrogensIBA 04/2014
1	Androgen Antagonists (Antiandrogens)IBA 04/2014
1	Chlormadinone Acetate (Chlormadinone)IBA 04/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2014
1	InterferonsIBA 02/2013
1	Analgesics (Analgesic Drugs)IBA 09/2012
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 09/2012
1	Warfarin (Coumadin)FDA LinkGeneric 02/2012
1	naftopidilIBA 01/2011
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2010
1	PolyphenolsIBA 06/2010
1	NitrosaminesIBA 06/2010
1	Guanosine Triphosphate (GTP)IBA 06/2010
1	von Willebrand FactorIBA 06/2010
1	Hematoxylin (Haematoxylon)IBA 06/2010
1	Anticarcinogenic AgentsIBA 06/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009
1	Proto-Oncogene Proteins c-metIBA 01/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006
1	Vascular Endothelial Growth Factor DIBA 02/2006
1	Vascular Endothelial Growth Factor CIBA 02/2006
1	Vascular Endothelial Growth FactorsIBA 02/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2005
1	Formaldehyde (Formol)FDA Link 01/2005
1	ParaffinIBA 01/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2005
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2004
1	VimentinIBA 11/2004
1	AntigensIBA 11/2004
1	Biological ProductsIBA 11/2004
1	ChromograninsIBA 11/2004
1	MucinsIBA 11/2004
1	Keratin-19 (Keratin 19)IBA 11/2004
1	Keratin-7 (Cytokeratin 7)IBA 11/2004
1	Matrix Metalloproteinases (MMPs)IBA 03/2004
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2004
1	Tissue Inhibitor of Metalloproteinase-2IBA 03/2004
1	Tissue Inhibitor of MetalloproteinasesIBA 03/2004
1	Epirubicin (Ellence)FDA LinkGeneric 10/2002
1	Fas Ligand Protein (Fas Ligand)IBA 03/2002

Therapy/Procedure

8	Therapeutics 01/2016 - 07/2002
3	Nephrectomy 02/2013 - 11/2002
1	Intramuscular Injections 02/2013
1	Aftercare (After-Treatment) 09/2012
1	Radiotherapy 07/2007
1	Drug Therapy (Chemotherapy) 07/2007
1	Intravesical Administration 10/2002
1	Adjuvant Chemotherapy 10/2002
1	Renal Dialysis (Hemodialysis) 07/2002